# OnCo record paper-gemstone-302-lancet-oncol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gemstone-302-lancet-oncol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gemstone-302-lancet-oncol-2022" ;
  schema:name "Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial"@en ;
  schema:description "Published report from the GEMSTONE-302 trial registered as NCT03789604, in The Lancet Oncology (2022), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-gemstone-302-lancet-oncol-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(21)00650-1>, <https://pubmed.ncbi.nlm.nih.gov/35038432/>, <https://europepmc.org/article/MED/35038432>, <https://clinicaltrials.gov/study/NCT03789604> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(21)00650-1> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Zhou C, Wang Z, Sun Y, et al." ;
  onco:trials <https://onco.cc/trials/gemstone-302/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .